Sotera Health’s (SHC) Underweight Rating Reiterated at JPMorgan Chase & Co.

Sotera Health (NASDAQ:SHC)‘s stock had its “underweight” rating reissued by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $17.00 price target on the stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 6.64% from the stock’s current price.

A number of other analysts also recently weighed in on the company. Weiss Ratings upgraded Sotera Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Barclays boosted their price objective on Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. UBS Group set a $19.00 price objective on Sotera Health in a research note on Wednesday, June 24th. Piper Sandler restated an “overweight” rating and set a $25.00 target price on shares of Sotera Health in a research report on Tuesday, September 8th. Finally, Citigroup raised their target price on Sotera Health from $23.00 to $25.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Nine research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and an average target price of $21.38.

Sotera Health Trading Up 0.3%

SHC opened at $18.21 on Wednesday. Sotera Health has a twelve month low of $13.09 and a twelve month high of $19.85. The company has a quick ratio of 2.55, a current ratio of 2.80 and a debt-to-equity ratio of 3.33. The company has a fifty day moving average of $18.71 and a 200-day moving average of $17.10. The stock has a market cap of $5.20 billion, a PE ratio of 21.35 and a beta of 1.85.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Thursday, August 6th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The business had revenue of $321.38 million during the quarter, compared to the consensus estimate of $309.70 million. Sotera Health had a net margin of 13.44% and a return on equity of 40.12%. Sotera Health’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 earnings per share. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, sell-side analysts predict that Sotera Health will post 0.87 EPS for the current year.

Insider Buying and Selling

In other news, insider Michael P. Rutz sold 150,000 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the completion of the sale, the insider owned 334,279 shares in the company, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the transaction, the chairman directly owned 3,969,393 shares in the company, valued at $73,433,770.50. The trade was a 17.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,294,515 shares of company stock valued at $23,999,528 in the last three months. Insiders own 15.36% of the company’s stock.

Institutional Trading of Sotera Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC grew its position in shares of Sotera Health by 3.0% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 19,443 shares of the company’s stock valued at $345,000 after acquiring an additional 559 shares during the period. GAMMA Investing LLC increased its stake in shares of Sotera Health by 7.4% during the 3rd quarter. GAMMA Investing LLC now owns 10,055 shares of the company’s stock worth $186,000 after purchasing an additional 694 shares during the last quarter. Strs Ohio raised its holdings in shares of Sotera Health by 20.1% in the 1st quarter. Strs Ohio now owns 5,881 shares of the company’s stock worth $84,000 after purchasing an additional 986 shares during the period. Maryland State Retirement & Pension System raised its holdings in shares of Sotera Health by 12.9% in the 1st quarter. Maryland State Retirement & Pension System now owns 11,292 shares of the company’s stock worth $162,000 after purchasing an additional 1,292 shares during the period. Finally, Empowered Funds LLC raised its holdings in shares of Sotera Health by 5.8% in the 1st quarter. Empowered Funds LLC now owns 24,177 shares of the company’s stock worth $347,000 after purchasing an additional 1,327 shares during the period. Institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company (NASDAQ:SHC) is a global provider of healthcare services focused on sterilization, laboratory testing and infection prevention. The company serves medical device manufacturers, pharmaceutical companies, biotechnology businesses, hospitals and other healthcare organizations.

Sotera Health operates through three primary businesses. Sterigenics provides outsourced sterilization and medical device services using technologies such as ethylene oxide, gamma irradiation and electron beam processing.